Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64

Archives of Neurology

Volumn 56, Issue 9, 1999, Pages 1152-1155

  Uemichi, Tomoyuki ^a,b   Uitti, Ryan J ^c   Koeppen, Arnulf H ^d   Donat, Jeffrey R ^e   Benson, Merrill D ^a,f  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c MAYO CLINIC   (United States)

^d STRATTON VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

^f Richard L Roudeboush Vet Aff M   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA; PHENYLALANINE; PREALBUMIN; SERINE; THYMINE;

ADULT; AMINO ACID SUBSTITUTION; AMYLOIDOSIS; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CODON; DNA SEQUENCE; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEPTOMENINX; MALE; NUCLEIC ACID BASE SUBSTITUTION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN VARIANT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AMYLOIDOSIS; AUTORADIOGRAPHY; CENTRAL NERVOUS SYSTEM DISEASES; CYTOSINE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENINGES; MUTATION; NERVOUS SYSTEM DISEASES; OCULOMOTOR NERVE; PEDIGREE; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREALBUMIN; SEQUENCE ANALYSIS, DNA; THYMINE;

EID: 0032886881     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.9.1152     Document Type: Article

References (30)

1. Benson MD. Amyloidosis. in: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York, NY: McGraw Hill Book Co; 1995:4159-4191.
2. Benson MD, Uemichi T. Transthyretin amyloidosis. Amyloid. 1996;3:44-56.
3. Schriber G, Richerdson SJ. The evolution of gene expression, structure and function of transthyretin. Comp Biochem Physiol B Biochem Mol Biol. 1997;116: 137-160.
4. Dwulet FE, Benson MD. Polymorphism of human plasma thyroxine binding prealbumin. Biochem Biophys Res Commun. 1983;114:657-662.
5. Uitti RJ, Donat JR, Rozdilsky B, Schneider RJ, Koeppen AH. Familial oculoleptomeningeal amyloidosis: report of a new family with unusual features. Arch Neurol. 1988;45:1118-1122.
6. Vidal R, Garzuly F, Budka H, et al. Meningocerebrovascular amyloidosis associated with a novel transthyretin (TTR) missense mutation at codon 18 (TTRD18G). Am J Pathol. 1996;148:361-366.
7. Madisen L, Hoar DI, Holroyd CD, Crisp M, Hodes ME. DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA. Am J Med Genet. 1987;27:379-390.
8. Nichols WC, Gregg RE, Brewer HB, Benson MD. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics. 1990;8: 318-323.
9. Nichols WC, Liepnieks JJ, McKusick VA, Benson MD. Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification. Genomics. 1989;5:535-540.
10. Tsuzuki T, Mita S, Maeda S, Araki S, Shimada K. Structure of human prealbumin gene. J Biol Chem. 1985;260:12224-12227.
11. Garzuly F, Wisniewski T, Brittig F, Budka H. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp1BGly). Neurology. 1996;47:1562-1567.
12. Goren H, Steinberg MC, Farboody GH. Familial oculoleptomeningeal amyloidosis. Brain. 1980;103:473-495.
13. Petersen RB, Goren H, Cohen M, et al. Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol. 1997;41:307-313.
14. Booth DR, Booth SE, Persey MR, et al. Three new amyloidogenic TTR mutations: PR012, GLU18, and VAL 33 [abstract]. Neuromuscul Disord. 1996;6 (suppl):S20.
15. Blake CCF, Geisow MJ, Oatley SJ, Rerat B, Rerat C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J Mol Biol. 1978;121:339-356.
16. Ii S, Minnerath S, Ii K, Dyck PJ, Sommer SS. Two-tiered DNA-based diagnosis of transthyretin amyloidosis reveals two novel point mutations. Neurology. 1991; 41:893-898.
17. Ferlini A, Salvi F, Uncini A, et al. Homozygosity and heterozygosity for the transthyretin Leu64 mutation: clinical, biochemical and molecular findings. Clin Genet. 1996;49:10-14.
18. Jones LA, Skare JC, Cohen AS, Harding JA, Milunsky A, Skinner M. Familial amyloidotic polyneuropathy: a new transthyretin position 30 mutation (alanine for valine) in a family of German descent. Clin Genet. 1992;41:70-73.
19. Nakazato M, Ikeda S, Shiomi K, et al. Identification of a novel transthyretin variant (Val30-Leu) associated with familial amyloidotic polyneuropathy. FEBS Lett. 1992;306:206-208.
20. Levy E, Carman MD, Fernandez-Madrid IJ, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 1990; 248:1124-1126.
21. Hendriks L, van Duijn CM, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat Genet. 1992;1:218-221.
22. Vinters. Cerebral amyloid angiopathy: a critical review. Stroke. 1987;18:311-324.
23. Ghiso J, Jensson O, Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci U S A. 1986;83:2974-2978.
24. Herbert J, Wilcox JN, Pham KT, et al. Transthyretin: a choroid plexus-specific transport protein in human brain. Neurology. 1986;36:900-911.
25. Weisner B, Roethig HJ. The concentration of prealbumin in cerebrospinal fluid: indicator of CSF circulation disorders. Eur Neurol. 1983;22:96-105.
26. Grubb A, Jensson O, Gudmundsson G, Arnason A, Lofberg H, Malm J. Abnormal metabolism of γ-trace alkaline microprotein: the basic defect in hereditary cerebral hemorrhage with amyloidosis. N Engl J Med. 1984;311:1547-1549.
27. Wisniewski HM, Frackowiak J, Mazur-Kolecka B. In vitro production of β-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci Lett. 1995;183:120-123.
28. Takahashi RH, Sawa H, Takada A, et al. Expression of amyloid precursor protein mRNA in vascular smooth muscle cells of the human brain. Neuropathology. 1997; 17:11-14.
29. Harats N, Worth R, Benson MD. Spinal claudication in systemic amyloidosis. J Rheumatol. 1989;16:1003-1006.
30. Benson MD. Leptomeningeal amyloid and variant transthyretins. Am J Pathol. 1996;148:351-354.